Skip navigation
sponsored by 

Swayze responding well to cancer treatment

Doctor tells People that actor will continue same therapy at Stanford

Mark Mainz / Getty Images file
Actor Patrick Swayze is having an "excellent response" to his pancreatic cancer treatment, his doctor told People magazine.
Access Hollywood video
  Denise Richards breaks down
July 24: Why does Denise Richards break down on the season finale of her reality show?  What did Gillian Anderson wear at "The X-Files" premiere?  Plus, a sneak peek at the new James Bond film.

Access Hollywood
updated 7:10 p.m. ET April 8, 2008

LOS ANGELES - Patrick Swayze has had an “excellent response” to his cancer treatment, a doctor for the actor told People.

In addition, Swayze told People the outpouring of support since announcing he had pancreatic cancer has been nothing short of spectacular.

“We’re thrilled and grateful for the positive response Patrick has shown towards his treatment. Also, we can’t help but feel that all the prayers, meditations and good thoughts sent his way by everyone has made a difference. Thank you!,” Swayze and his wife, Lisa Niemi, told People.

Story continues below ↓
advertisement

Meanwhile, Swayze’s doctor said the former “Ghost” and “Dirty Dancing” star is making tremendous progress in his treatment.

“Patrick Swayze continues to respond well to his treatment for pancreatic cancer. Because of his excellent response, he will continue the same therapy at Stanford,” Dr. George Fisher told People.

In early March, a rep for Swayze confirmed to Access Hollywood the 55-year-old actor had been diagnosed with pancreatic cancer.

Swayze had been undergoing chemotherapy, as well as taking the experimental drug Vatalanib to cut off the blood supply to the tumor.

Copyright 2008 by NBC. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sponsored links

Resource guide

Get Your 2008 Credit Score

Search Jobs

Find your next car

Find Your Dream Home

Find a business to start

$7 trades, no fee IRAs